XRCC1 and ERCC1 variants modify malignant mesothelioma risk: a case-control study.

Area of Science:

• Genetics
• Oncology
• Environmental Health

Background:

• Malignant pleural mesothelioma (MPM) is a rare, aggressive cancer strongly linked to asbestos exposure.
• Genetic factors, including single nucleotide polymorphisms (SNPs) in metabolism genes, are also implicated in MPM development.
• Previous studies suggested an association between the DNA repair gene XRCC1 and MPM in asbestos-polluted areas.

Purpose of the Study:

• To investigate the association between genetic variations in DNA repair genes and MPM risk.
• To extend previous findings on XRCC1 and explore other candidate genes in MPM carcinogenicity.
• To assess the combined effect of specific gene variants on MPM risk in asbestos-exposed populations.

Main Methods:

• Two case-control studies were conducted with 220 MPM patients and 296 controls.
• Genotyping was performed for 35 SNPs in 15 candidate genes.
• Unconditional multivariate logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (95% CIs).

Main Results:

• Significant associations were found between MPM and two DNA repair genes: XRCC1 and ERCC1.
• Increased risk was observed with specific XRCC1 alleles (e.g., -399Q, -77T) and a particular XRCC1 haplotype (TGGGGGAACAGA), especially in asbestos-exposed individuals.
• Heterozygosity for ERCC1 N118N and the combined presence of ERCC1 N118N and XRCC1 R399Q variants showed statistically significant increased risk for MPM.

Conclusions:

• The study supports the hypothesis that genetic variations in DNA repair genes contribute to MPM susceptibility.
• An increased susceptibility to DNA damage due to specific genetic profiles may enhance asbestos carcinogenicity.
• These findings highlight the role of DNA repair gene polymorphisms in the development of asbestos-related mesothelioma.